Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,768Revenue (TTM) $M2,867Net Margin (%)19.2Altman Z-Score10.4
Enterprise Value $M20,168EPS (TTM) $2.5Operating Margin %27.2Piotroski F-Score8
P/E(ttm)38.4Beneish M-Score-2.0Pre-tax Margin (%)24.6Higher ROA y-yY
Price/Book7.710-y EBITDA Growth Rate %19.0Quick Ratio3.3Cash flow > EarningsY
Price/Sales7.45-y EBITDA Growth Rate %28.0Current Ratio4.1Lower Leverage y-yY
Price/Free Cash Flow51.5y-y EBITDA Growth Rate %26.8ROA % (ttm)13.7Higher Current Ratio y-yY
Dividend Yield %--PEG1.4ROE % (ttm)22.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M214ROIC % (ttm)31.4Gross Margin Increase y-yN

Gurus Latest Trades with EW

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EWJoel Greenblatt 2016-09-30 Sold Out -0.01%$98.58 - $121.22
($112.98)
$ 97.13-14%Sold Out0
EWRon Baron 2016-09-30 Reduce-0.01%$98.58 - $121.22
($112.98)
$ 97.13-14%Reduce -65.17%10,762
EWRon Baron 2016-06-30 Reduce-0.24%$88.21 - $108.93
($102.42)
$ 97.13-5%Reduce -94.15%30,903
EWJoel Greenblatt 2016-06-30 Buy 0.01%$88.21 - $108.93
($102.42)
$ 97.13-5%New holding5,837
EWVanguard Health Care Fund 2016-03-31 Sold Out -0.51%$74.52 - $89.56
($82.56)
$ 97.1318%Sold Out0
EWRon Baron 2016-03-31 Reduce-0.05%$74.52 - $89.56
($82.56)
$ 97.1318%Reduce -20.41%528,665
EWVanguard Health Care Fund 2015-12-31 Add0.14%$72.16 - $82.56
($78.04)
$ 97.1324%Add 36.80%3,217,520
EWRon Baron 2015-12-31 Add0.11%$72.16 - $82.56
($78.04)
$ 97.1324%Add 87.82%664,199
EWJoel Greenblatt 2015-12-31 Sold Out -0.01%$72.16 - $82.56
($78.04)
$ 97.1324%Sold Out0
EWVanguard Health Care Fund 2015-09-30 Reduce-0.3%$66.95 - $78.36
($72.41)
$ 97.1334%Reduce -30.88%4,704,120
EWJoel Greenblatt 2015-09-30 Reduce-0.12%$66.95 - $78.36
($72.41)
$ 97.1334%Reduce -92.99%15,554
EWRon Baron 2015-09-30 Reduce-0.01%$66.95 - $78.36
($72.41)
$ 97.1334%Reduce -6.81%707,254
EWJoel Greenblatt 2015-06-30 Reduce-0.14%$61.93 - $73.09
($67.76)
$ 97.1343%Reduce -54.07%221,828
EWRon Baron 2015-06-30 Reduce-0.1%$61.93 - $73.09
($67.76)
$ 97.1343%Reduce -33.54%758,932
EWJoel Greenblatt 2015-03-31 Reduce-0.01%$62.68 - $74.47
($67.3)
$ 97.1344%Reduce -2.59%482,934
EWRon Baron 2015-03-31 Reduce$62.68 - $74.47
($67.3)
$ 97.1344%Reduce -1.01%1,141,976
EWVanguard Health Care Fund 2014-12-31 Reduce-0.21%$49.02 - $66.74
($60.41)
$ 97.1361%Reduce -19.13%6,805,340
EWRon Baron 2014-12-31 Reduce-0.11%$49.02 - $66.74
($60.41)
$ 97.1361%Reduce -31.07%1,153,672
EWJoel Greenblatt 2014-12-31 Reduce-0.03%$49.02 - $66.74
($60.41)
$ 97.1361%Reduce -9.20%495,752
EWVanguard Health Care Fund 2014-09-30 Reduce-0.16%$42.22 - $52.01
($47.36)
$ 97.13105%Reduce -14.48%8,414,940
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EW is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EW: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MUSSALLEM MICHAEL AChairman & CEO 2016-12-19Sell49,100$91.965.62view
WANG HUIMINCVP, Japan & Intercontinental 2016-12-05Sell13,650$83.5316.28view
Wood Larry LCVP, THV Replacement 2016-12-01Sell13,258$81.8518.67view
Szyman Catherine M.CVP, Critical Care & Vascular 2016-11-30Buy12,870$83.4316.42view
LINK WILLIAM J PHDDirector 2016-11-29Sell15,000$84.0115.62view
GALLAHUE KIERANDirector 2016-11-29Buy3,000$84.6314.77view
MUSSALLEM MICHAEL AChairman & CEO 2016-11-22Sell49,100$84.6714.72view
WANG HUIMINCVP, Japan & Intercontinental 2016-11-07Sell13,650$91.296.4view
BOBO DONALD E JRCVP, Heart Valve Therapy 2016-11-02Sell15,000$90.137.77view
Wood Larry LCVP, THV Replacement 2016-11-01Sell13,257$93.274.14view

Press Releases about EW :

Quarterly/Annual Reports about EW:

News about EW:

Articles On GuruFocus.com
Weekly Top Insider Buys Highlight for the Week of Dec. 2 Dec 04 2016 
Medtronic Misses 2nd Quarter Revenue Expectations Nov 27 2016 
Numerous Companies Reach Yearly Highs Oct 03 2016 
7 Stocks with Strong Returns and Profitability Aug 04 2016 
Sam Isaly's Top Investments of the Year Aug 01 2016 
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Jun 18 2016 
Vanguard Sells Out Edwards Lifesciences May 03 2016 
Sands Capital Boosts Stake in Edwards Lifesciences Mar 09 2016 
Frank Sands Acquires Stake in Netflix Feb 23 2016 

More From Other Websites
Cramer’s exec cut: The secret to competing with Amazon in... Jan 13 2017
Edwards Lifesciences Is Recovering From a Bearish Gap Jan 11 2017
Medtronic Downgraded On Increased Boston, J&J, St. Jude Rivalries Jan 03 2017
Edwards Lifesciences To Present At The 35th Annual J.P. Morgan Healthcare Conference Jan 03 2017
Edwards Lifesciences upgraded by Guggenheim Jan 03 2017
Edwards Lifesciences Corp. – Value Analysis (NYSE:EW) : December 27, 2016 Dec 27 2016
Edwards Lifesciences Corp. breached its 50 day moving average in a Bullish Manner : EW-US : December... Dec 26 2016
Inside Edwards Lifesciences’ Financial Guidance for 2017 Dec 20 2016
These 5 Health Care Stocks Are Breaking Out This Christmas Dec 20 2016
Understanding the Key Drivers of EW’s Critical Care Business Growth Dec 19 2016
Where Is EW’s SHV Therapy Segment Headed after Disappointing 3Q16 Sales? Dec 19 2016
Edwards Lifesciences’ Acquisition of Valtech Cardio: Must-Know Details Dec 19 2016
New Structural Heart Initiatives: Edwards’ Key Growth Drivers in 2017 and Beyond Dec 16 2016
Inside Edwards Lifesciences’ THV Product Pipeline and Future Growth Estimates Dec 16 2016
Edwards Lifesciences Riding High on TAVR Sales Growth and Future Opportunities Dec 16 2016
Edwards Lifesciences Sees Growth on Long-Term Growth Strategy Dec 15 2016
Is Edwards Lifesciences Stock Recovering from Its Recent Declining Trend? Dec 15 2016
The Word on the Street: What Analysts Are Recommending for Edwards Lifesciences Now Dec 15 2016
Edwards' Life Goes On Without Big M&A Dec 12 2016
4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy Dec 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)